Methods of administering (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
Wikstrom, Hakan,Jorgensen, Morten,Mork, Niels,Larsen, Jennifer,Bang-Andersen, Benny,Sager, Thomas Nikolaj,Puschl, Ask,Torup, Lars
申请号：
AU2013206198
公开号：
AU2013206198A1
申请日:
2013.06.06
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013206198A120130627.pdf#####METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL1,2,3,4,4A,5,10,IOA-OCTAHYDROBENZO[G]QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF ABSTRACT Disclosed are pharmaceutical compositions and methods for the administration of (4aR, 1 OaR)-ln-propyl- 1,2,3,4,4a,5, 10,1 Oa-octahydro-benzo [g] quinoline-6,7-diol or a pharmaceutically acceptable salt thereof and related compounds for the treatment of neurological disorder such as Parkinsons disease and restless leg syndrome.
